Lax SF, Petru E, Holzer E, Pertl AM, Ralph G, Greenspan DL, Berger A, Jatzko G. Mesenteric and mesocolic lymph node metastases from ovarian carcinoma: a clinicopathological analysis. Int J Gynecol Cancer 1998; 8:119–123.
The aim of this study was to analyze the clinicopathological features of ovarian carcinomas with metastases to mesenteric or mesocolic lymph nodes. Thirty patients with primary ovarian carcinomas metastatic to the bowel were analyzed for the extent of bowel infiltration, lymph node involvement, lymphatic channel involvement, and the number of examined lymph nodes. Metastases to mesenteric or mesocolic lymph nodes were found in 20 of the 30 patients. Metastases to mesenteric/mesocolic lymph nodes were more frequently associated with lymph vascular invasion at the site of the bowel implants and metastatic involvement of multiple bowel segments compared to mesenteric/mesocolic node‐negative cases (
P < 0.04). There was no significant difference between the mesenteric/mesocolic node‐positive and node‐negative patients with regard to FIGO stage, histologic type, tumor grade, residual tumor after surgery, gross pattern of bowel metastases, and involvement of retroperitoneal lymph nodes. While the presence of mesenteric/mesocolic lymph node metastases tended to be associated with shorter survival, this was not statistically significant. The prognostic and putative therapeutic importance of positive mesenteric/mesocolic lymph nodes in ovarian carcinoma awaits further evaluation in a larger number of cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.